This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nikolaos Mellios and RNA-Based Approaches to Depression Treatment
Introduction
Nikolaos Mellios is an inventor associated with Albuquerque, New Mexico, and The University of Texas System. His patent work concerns circular RNAs as potential tools for diagnosing depression and predicting responses to antidepressant treatment.
Latest Patents
Mellios is associated with 1 patent: “Circular RNAs for Diagnosis of Depression and Prediction of Response to Antidepressant Treatment.” The invention focuses on using circular RNA markers to support depression diagnosis and help anticipate how a patient may respond to antidepressant therapy.
Career Highlights
The available information identifies Mellios as an inventor on a patent addressing molecular approaches to mental health care. The work reflects an effort to connect biological markers with diagnosis and treatment planning.
Collaborations
The patent is associated with The University of Texas System, indicating an institutional connection to the research and intellectual property.
Conclusion
Nikolaos Mellios’s patent highlights the potential role of circular RNA research in improving depression diagnosis and informing antidepressant treatment decisions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile